2019.02 Noiʻi Genome Hōʻike ʻo Guide Positioning Sequencing i nā hiʻohiʻona methylation DNA aberrant e hoʻololi i ka ʻike kelepona a me nā pūnaewele nānā ʻana i ka tumor-immune. IF: 11.093 ʻOi aku 2019.10 Noi'i ma'i 'a'ai ʻO nā genes pili i ka histone ka hypermethylated i ka maʻi kanesa a me ka hypermethylatedHIST1H4Fhiki ke lawelawe ma ke ʻano he pan-cancer biomarker IF: 13.312 ʻOi aku 2021.06 lāʻau lapaʻau lapaʻau a unuhi HypermethylatedPCDHGB7ma ke ʻano he hōʻailona maʻi maʻi āpau wale nō a me kāna noi ʻana i ka nānā ʻana i ka maʻi maʻi cervical mua IF: 11.492 ʻOi aku 2022.01 Frontiers i loko o ka Molecular Biosciences HypermethylatedPCDHGB7ma ke ʻano he biomarker no ka ʻike mua ʻana i ka maʻi maʻi endometrial i nā laʻana palalaki endometrial a me nā ʻōpala ʻāʻī IF: 6.113 ʻOi aku 2022.07 Hoʻololi ʻana i nā hōʻailona a me ka Lapaʻau ʻia Hoʻololi epigenetic kūʻokoʻa i kekahiEono6me ka hypermethylation no ka pae precancerous a me ka huli ʻana o ka metastasis IF: 38.104 ʻOi aku
